Steven Gannon

This profile gathers the share dealings of Steven Gannon in Xenon Pharmaceuticals Inc. We count 20 filings; the first trade dates from 21 May 2015 and the latest from 11 August 2026.

The open-market side counts 1 purchase for €28k alongside 6 sales for €727k. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 7 option exercises. Since January 2026: no purchases and 2 sales on the market.

The newest entry dates from 14 August 2026: an open-market sale of €319k, in Xenon Pharmaceuticals Inc. The latest purchase dates back some time: it was published 3,359 days ago, on 14 August 2017. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.